Using Stress Testing to Guide Primary Prevention of Coronary Heart Disease Among Intermediate-Risk Patients
Author(s) -
Benjamin Z. Galper,
Andrew E. Moran,
Pamela G. Coxson,
Mark J. Pletcher,
Paul A. Heidenreich,
Lawrence D. Lazar,
Nicolas Rodondi,
Y. Claire Wang,
Lee Goldman
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.041293
Subject(s) - medicine , aspirin , stress testing (software) , statin , coronary heart disease , pill , disease , intensive care medicine , cost effectiveness , physical therapy , heart disease , cardiology , pharmacology , risk analysis (engineering) , computer science , programming language
Noninvasive stress testing might guide the use of aspirin and statins for primary prevention of coronary heart disease, but it is unclear if such a strategy would be cost effective.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom